Management of aggressive lymphoma after CAR T-cell therapy failure.

Nastoupil, Loretta J; Kambhampati, Swetha

Nastoupil, Loretta J; Kambhampati, Swetha.

Affiliation

Nastoupil LJ; UT MD Anderson Cancer Center, Department of Lymphoma/Myeloma Houston, TX.
Kambhampati S; City of Hope National Medical Center, Department of Hematology & Hematopoietic Cell Transplantation, Duarte, CA.

Hematology Am Soc Hematol Educ Program ; 2023(1): 364-369, 2023 Dec 08.

Article in En | MEDLINE | ID: mdl-38066908

Subject(s)

Immunotherapy, Adoptive; Lymphoma, Large B-Cell, Diffuse; Humans; Immunotherapy, Adoptive/adverse effects; Receptors, Antigen, T-Cell/genetics; Prospective Studies; Neoplasm Recurrence, Local/etiology; Lymphoma, Large B-Cell, Diffuse/pathology; Antigens, CD19; Recurrence

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Lymphoma, Large B-Cell, Diffuse Limits: Humans Language: En Journal: Hematology Am Soc Hematol Educ Program Journal subject: HEMATOLOGIA Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google